About HBM Partners
HBM BioCapital (EUR) L.P. and HBM BioCapital (USD) L.P. are private equity funds with a total committed capital of EUR 115 million. The funds are managed by HBM Partners and are focused on healthcare / life science investments in Europe and the U.S. They were launched in 2005. HBM BioCapital I has made investments in 15 private companies in the pharma, biotechnology, medical devices and diagnostics industries, seven of which have been sold or listed on a stock exchange. Larger transactions were shared with HBM BioVentures. Investors in HBM BioCapital I are HBM BioVentures, larger institutional investors and pharma entrepreneurs.
HBM Partners Headquarter Location
+41 43 888 7171
HBM Partners Team
3 Team Members
HBM Partners has 3 team members, including current Chief Executive Officer, Andreas Wicki.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.